Aegerion Pharmaceuticals, Inc.: 10-Q filed 2012-05-10
What Aegerion Pharmaceuticals, Inc. reported in its quarterly report filed 2012-05-10 (fiscal Q1 2012): 35 published measures, 86 facts as tagged in accession 0001193125-12-224870.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2012-05-10
- Fiscal period
- fiscal Q1 2012
- Accession
- 0001193125-12-224870 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Aegerion Pharmaceuticals, Inc. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-03-31 | 65,599,823 | USD | |
| At 2011-12-31 | 75,568,159 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-03-31 | 16,759,536 | USD | |
| At 2011-12-31 | 18,366,818 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-03-31 | 48,840,287 | USD | |
| At 2011-12-31 | 57,201,341 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-03-31 | 31,883,550 | USD | |
| At 2011-12-31 | 26,368,080 | USD | |
| At 2011-03-31 | 46,827,763 | USD | |
| At 2010-12-31 | 44,100,897 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-03-31 | -11,665,145 | USD | 91 |
| 2005-02-04 to 2012-03-31 | -130,387,169 | USD | 2613 |
| 2011-01-01 to 2011-03-31 | -6,832,458 | USD | 90 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-03-31 | -8,794,462 | USD | 91 |
| 2005-02-04 to 2012-03-31 | -102,447,474 | USD | 2613 |
| 2011-01-01 to 2011-03-31 | -7,009,916 | USD | 90 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-03-31 | 135,926 | USD | 91 |
| 2005-02-04 to 2012-03-31 | 871,139 | USD | 2613 |
| 2011-01-01 to 2011-03-31 | 73,418 | USD | 90 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-03-31 | -462,324 | USD | 91 |
| 2005-02-04 to 2012-03-31 | 169,221,651 | USD | 2613 |
| 2011-01-01 to 2011-03-31 | 9,810,200 | USD | 90 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-03-31 | 14,764,074 | USD | 91 |
| 2005-02-04 to 2012-03-31 | -34,873,948 | USD | 2613 |
| 2011-01-01 to 2011-03-31 | -73,418 | USD | 90 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-03-31 | -142,122,118 | USD | |
| At 2011-12-31 | -130,456,973 | USD |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2005-02-04 to 2012-03-31 | -1,793,129 | USD | 2613 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-03-31 | 629,000 | USD | |
| At 2011-12-31 | 526,353 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-03-31 | 2,112,599 | USD | 91 |
| 2005-02-04 to 2012-03-31 | 14,645,994 | USD | 2613 |
| 2011-01-01 to 2011-03-31 | 1,261,839 | USD | 90 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-03-31 | -10,576,504 | USD | 91 |
| 2005-02-04 to 2012-03-31 | -124,300,332 | USD | 2613 |
| 2011-01-01 to 2011-03-31 | -6,787,455 | USD | 90 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-03-31 | 64,500,930 | USD | |
| At 2011-12-31 | 74,076,612 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-03-31 | 327,748 | USD | 91 |
| 2005-02-04 to 2012-03-31 | 8,339,294 | USD | 2613 |
| 2011-01-01 to 2011-03-31 | 112,527 | USD | 90 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-03-31 | 6,951,314 | USD | |
| At 2011-12-31 | 9,400,388 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-03-31 | 1,853,416 | USD | |
| At 2011-12-31 | 2,798,283 | USD |
Common-stock repurchase payments
Cash paid to reacquire common stock during the period. This is not an authorization limit or a direct measure of the net change in share count.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2005-02-04 to 2012-03-31 | 373 | USD | 2613 |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-03-31 | 10,576,504 | USD | 91 |
| 2005-02-04 to 2012-03-31 | 124,300,332 | USD | 2613 |
| 2011-01-01 to 2011-03-31 | 6,787,455 | USD | 90 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-03-31 | 4,634,842 | USD | 91 |
| 2005-02-04 to 2012-03-31 | 78,935,103 | USD | 2613 |
| 2011-01-01 to 2011-03-31 | 3,449,941 | USD | 90 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-03-31 | 21,574,287 | shares | |
| At 2011-12-31 | 21,200,292 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-03-31 | 190,932,181 | USD | |
| At 2011-12-31 | 187,685,380 | USD |
Accumulated other comprehensive income or loss
Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-03-31 | 8,919 | USD | |
| At 2011-12-31 | -47,997 | USD |
Long-term debt
Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-03-31 | 9,722,223 | USD | |
| At 2011-12-31 | 8,124,998 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-03-31 | 365,001 | USD | |
| At 2011-12-31 | 860,302 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-03-31 | 4,820,121 | USD | |
| At 2011-12-31 | 4,727,103 | USD |
Prepaid expenses and other current assets
Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-03-31 | 991,815 | USD | |
| At 2011-12-31 | 913,845 | USD |
Comprehensive income or loss
Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-03-31 | -11,608,229 | USD | 91 |
| 2005-02-04 to 2012-03-31 | -154,041,663 | USD | 2613 |
| 2011-01-01 to 2011-03-31 | -6,727,458 | USD | 90 |
Net income available to common stockholders
Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-03-31 | -11,665,145 | USD | 91 |
| 2005-02-04 to 2012-03-31 | -154,050,582 | USD | 2613 |
| 2011-01-01 to 2011-03-31 | -6,832,458 | USD | 90 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-03-31 | 5,111,144 | USD | 91 |
| 2005-02-04 to 2012-03-31 | 43,622,737 | USD | 2613 |
| 2011-01-01 to 2011-03-31 | 3,337,514 | USD | 90 |
Depreciation expense
Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-03-31 | 32,640 | USD | 91 |
| 2005-02-04 to 2012-03-31 | 165,313 | USD | 2613 |
| 2011-01-01 to 2011-03-31 | 1,410 | USD | 90 |
Other nonoperating income or expense
Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-03-31 | -801,936 | USD | 91 |
| 2005-02-04 to 2012-03-31 | 221,073 | USD | 2613 |
Interest paid, net
Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-03-31 | 340,889 | USD | 91 |
| 2005-02-04 to 2012-03-31 | 3,843,546 | USD | 2613 |
| 2011-01-01 to 2011-03-31 | 89,556 | USD | 90 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-03-31 | -945,661 | USD | 91 |
| 2005-02-04 to 2012-03-31 | 840,362 | USD | 2613 |
| 2011-01-01 to 2011-03-31 | -836,254 | USD | 90 |
Inspect the source
- Entity
- Aegerion Pharmaceuticals, Inc. / CIK 0001338042
- Captured
- SEC response SHA-256
522c3af406e78cbef92d1883c63bfd97552757d1256ec392d9c3136363668fca
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001338042.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))